BioCentury
ARTICLE | Clinical News

L-Annamycin: Phase I/II started

December 12, 2005 8:00 AM UTC

KAL started an open-label, U.S. Phase I/II trial in up to 34 relapsed or refractory adult ALL patients. The Phase I portion of the trial will be dose-escalating in about 12 patients. ...